Lumicell Diagnostics
PrivateLast Round
Series D
Extension
Apr 22, 2025
Est. Valuation
$250M
Total Funding Raised
$144.31M
Momentum Score
50 /100
Company Overview
Lumicell is a medical device company that develops innovative oncology surgical devices aimed at enhancing cancer surgery by utilizing an optical contrast agent and advanced imaging technology to identify and remove residual cancer cells in real-time.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Medical Imaging, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lumicell Diagnostics Comps
Public and private peers based on sector, stage, and business model.
Lumicell Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Apr 22, 2025 | ||||
| Series D | Jul 11, 2024 | ||||
| Series C | Feb 22, 2024 | ||||
| Series D | Jul 26, 2023 | ||||
| Series C | Dec 6, 2018 | ||||
Series C | Dec 7, 2017 |
Key People
Founding team and executive leadership
Lumicell Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Furneaux Capital | Series D |
| Kodiak Venture Partners | Series C |
| BlueIO | Series D, Series C |
| Rivas Capital | Series D |
| Kinled Holding | Series D |
| Burch Creative Capital | Series D |
| Launch Capital | Series A, Series D, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Fluorescence-guided surgery platform is now a commercially approved Class III medical device.
- Mar 1, 2026
Expanding commercial launch of breast cancer surgery drug/device product.
Lumicell Diagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lumicell Diagnostics's valuation, stock price, and market status.
